These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31796124)

  • 1. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
    Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
    Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
    Bengoa-Vergniory N; Velentza-Almpani E; Silva AM; Scott C; Vargas-Caballero M; Sastre M; Wade-Martins R; Alegre-Abarrategui J
    Acta Neuropathol Commun; 2021 Jan; 9(1):18. PubMed ID: 33509301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validated antibody panel for the characterization of tau post-translational modifications.
    Ercan E; Eid S; Weber C; Kowalski A; Bichmann M; Behrendt A; Matthes F; Krauss S; Reinhardt P; Fulle S; Ehrnhoefer DE
    Mol Neurodegener; 2017 Nov; 12(1):87. PubMed ID: 29157277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
    Kalyaanamoorthy S; Opare SK; Xu X; Ganesan A; Rao PPN
    Curr Alzheimer Res; 2024; 21(1):24-49. PubMed ID: 38623984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.
    Ferrer I; Andrés-Benito P; Ausín K; Pamplona R; Del Rio JA; Fernández-Irigoyen J; Santamaría E
    Brain Pathol; 2021 Nov; 31(6):e12996. PubMed ID: 34218486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.
    Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Sarmiento J; Troncoso J; Jackson GR; Kayed R
    FASEB J; 2012 May; 26(5):1946-59. PubMed ID: 22253473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of different tau sites during progression of Alzheimer's disease.
    Neddens J; Temmel M; Flunkert S; Kerschbaumer B; Hoeller C; Loeffler T; Niederkofler V; Daum G; Attems J; Hutter-Paier B
    Acta Neuropathol Commun; 2018 Jun; 6(1):52. PubMed ID: 29958544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease.
    Velásquez E; Szeitz B; Gil J; Rodriguez J; Palkovits M; Renner É; Hortobágyi T; Döme P; Nogueira FC; Marko-Varga G; Domont GB; Rezeli M
    Front Immunol; 2021; 12():750665. PubMed ID: 34712240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible link between astrocyte activation and tau nitration in Alzheimer's disease.
    Reyes JF; Reynolds MR; Horowitz PM; Fu Y; Guillozet-Bongaarts AL; Berry R; Binder LI
    Neurobiol Dis; 2008 Aug; 31(2):198-208. PubMed ID: 18562203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
    Kovacech B; Novak M
    Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
    Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
    Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer's disease.
    Bichmann M; Prat Oriol N; Ercan-Herbst E; Schöndorf DC; Gomez Ramos B; Schwärzler V; Neu M; Schlüter A; Wang X; Jin L; Hu C; Tian Y; Ried JS; Haberkant P; Gasparini L; Ehrnhoefer DE
    Mol Neurodegener; 2021 Jul; 16(1):46. PubMed ID: 34215303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease.
    Reynolds MR; Berry RW; Binder LI
    Biochemistry; 2005 Feb; 44(5):1690-700. PubMed ID: 15683253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
    Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
    Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.